Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of T-Cell Response in Subjects Previously Treated With JNJ-54861911 (Atabecestat)

NCT03587376 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

NCT NCT03587376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03587376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of T-Cell Response in Subjects Previously Treated With JNJ-54861911 (Atabecestat)
Lead sponsor
Janssen Research & Development, LLC
Phase
Phase 1
Overall status
Completed
Start date
May 30, 2018
Completion date
August 23, 2018
Enrollment
9 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease